Show simple item record

dc.contributor.authorBese, T
dc.contributor.authorNomir, SK
dc.date.accessioned2021-03-06T12:47:45Z
dc.date.available2021-03-06T12:47:45Z
dc.date.issued2001
dc.identifier.citationBese T., Nomir S., "The importance of serum insulin-like growth factor-I level determination in the follow-up of patients with epithelial ovarian cancer", EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, cilt.22, ss.372-376, 2001
dc.identifier.issn0392-2936
dc.identifier.othervv_1032021
dc.identifier.otherav_f5965654-31fa-4752-8dbc-e32aa66fd729
dc.identifier.urihttp://hdl.handle.net/20.500.12627/160956
dc.description.abstractPurpose of investigation: The aim of our study was to assess whether serum levels of serum insulin-like growth factor-I (IGF-I) could be used for the follow-up of the patients with epithelial ovarian cancer and to identify whether it was superior to serum CA 125.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleThe importance of serum insulin-like growth factor-I level determination in the follow-up of patients with epithelial ovarian cancer
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume22
dc.identifier.issue5
dc.identifier.startpage372
dc.identifier.endpage376
dc.contributor.firstauthorID127281


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record